Renal Response of Pomalidomide with Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study
机构:[1]Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China北京朝阳医院[2]Chinese Acad Med Sci & Peking Union Med Coll, Dept Hematol, Peking Union Med, Beijing, Peoples R China[3]Kunming Med Univ, Hematol Res Ctr Yunnan Prov, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China昆明医科大学附属第一医院[4]Chifeng Municipal Hosp, Chifeng, Peoples R China[5]Yantai Yuhuangding Hosp, Dept Hematol, Yantai, Shandong, Peoples R China[6]Hebei Med Univ, Hosp 2, Shijiazhuang, Hebei, Peoples R China[7]Gen Hosp Chinese Peoples Liberat Army, Med Ctr 5, Beijing, Peoples R China[8]Changzhi Med Coll, Leping Hosp, Changzhi, Peoples R China[9]Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China[10]Inner Mongolia Univ Secience & Technol, Baotou Med Coll, Affiliated Hosp 1, Baotou, Peoples R China内蒙古科技大学包头医学院[11]Third Peoples Hosp Datong, Datong, Peoples R China[12]Linfen Peoples Hosp, Linfen, Shanxi, Peoples R China[13]Harbin Med Univ, Affiliated Hosp 1, Harbin, Peoples R China[14]Shanxi Med Univ, Dept Hematol, Hosp 2, Taiyuan, Peoples R China[15]Binzhou Med Univ, Yantaishan Hosp, Yantai, Peoples R China[16]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China河北医科大学第四医院[17]Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China[18]Beijing Jishuitan Hosp, Beijing, Peoples R China[19]Peking Univ, Dept Hematol, Hosp 1, Beijing, Peoples R China[20]Capital Med Univ, Beijing Luhe Hosp, Dept Hematol, Beijing, Peoples R China[21]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China华中科技大学同济医学院附属协和医院[22]Cangzhou Cent Hosp, Cangzhou, Peoples R China[23]Bayannur Hosp, Bayannur, Peoples R China[24]Ordos Cent Hosp, Ordos, Peoples R China[25]Shanxi Canc Hosp, Dept Hematol, Taiyuan, Peoples R China[26]Jilin Univ, Hosp 1, Changchun, Peoples R China[27]Shanxi Bethune Hosp, Taiyuan, Peoples R China[28]Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China大连医科大学附属第一医院[29]Peking Univ, Dept Hematol, Hosp 3, Beijing, Peoples R China[30]Inner Mongolia Med Univ, Affiliated Hosp, Hohhot, Peoples R China[31]Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China
第一作者机构:[1]Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Jian Yuan,Chang Long,Shi Mingxia,et al.Renal Response of Pomalidomide with Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study[J].BLOOD.2022,140:10167-10169.doi:10.1182/blood-2022-159361.
APA:
Jian, Yuan,Chang, Long,Shi, Mingxia,Sun, Ying,Chu, Xiaoxia...&Gao, Wen.(2022).Renal Response of Pomalidomide with Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study.BLOOD,140,
MLA:
Jian, Yuan,et al."Renal Response of Pomalidomide with Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study".BLOOD 140.(2022):10167-10169